Global Intravenous Solutions Market Overview 2018, Demand by Regions, Types and Analysis of Key Players

The global intravenous solutions market has been witnessing a steady growth over the years. This can be accredited to the introduction of new product variants by the manufacturers along with increasing healthcare investments in the developing regions.

Request a free sample report: https://www.imarcgroup.com/request?type=report&id=891&flag=B

The latest report by IMARC Group, titled “Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global intravenous solution market reached a value of more than US$ 7 Billion in 2016. Intravenous solutions refer to the fluids which are administrated into a vein by means of a steel needle or plastic catheter. They are a combination of essential nutrients that helps in sustaining strength, facilitating faster recovery and maintaining hydration levels in patients. Intravenous solutions also help in the homeostasis of the body by maintaining its fluid and electrolyte balance. In addition to this, they are extensively used by the geriatric population and to treat people suffering from conditions like diabetes and cancer, and unhealthy eating habits.

Highlights of the global intravenous solutions market:

  • Portable packaging of intravenous solutions is expected to be the major demand driver.
  • North America represents the largest producer, accounting for the majority of the global production.
  • The market is projected to reach a value of around US$ 11 Billion by 2022.

The major factor driving the growth of the intravenous solutions market is the availability of intravenous products in portable packaging which makes it easier for consumers to use them in a home setting as well. Additionally, through innovation, vendors are able to offer premixed products for increased convenience and reduced waste and disposal costs which is further likely to impact the market growth. Further, with the rising prevalence of chronic diseases and gastrointestinal disorders, the adoption of intravenous solutions is rising among the consumers. Moreover, the governments in the developing countries are increasing the investment in the healthcare sector, thereby driving the demand for intravenous solutions. According to the report, the global intravenous solutions market is expected to reach a value of around US$ 11 Billion by 2022, exhibiting a CAGR of 6.5% during 2017-2022.

On the basis of product type, the market is segmented into partial and total parenteral nutrition. The market is further segregated on the basis of nutrients into carbohydrates, salts and electrolytes, minerals, vitamins and amino acids. Based on region, North America currently holds the majority of the global intravenous solutions market, followed by Europe and Asia Pacific. Other major regions include the Middle East and Africa, and Latin America. On evaluating the competitive landscape of the market, it is found that the major players are Ajinomoto, B. Braun Melsungen, Baxter International Inc., Grifols and Otsuka Pharmaceutical.

Read full report with TOC: https://www.imarcgroup.com/intravenous-solutions-market

The report by IMARC Group has examined the global intravenous solutions market on the basis of:

Product Type:

  • Partial Parenteral Nutrition
  • Total Parenteral Nutrition

Nutrients: 

  • Carbohydrates
  • Salts and Electrolytes
  • Minerals
  • Vitamins
  • Amino Acids

Region: 

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Key Players: 

  • Ajinomoto
  • B. Braun Melsungen
  • Baxter International Inc.
  • Grifols
  • Otsuka Pharmaceutical

Browse related reports: 

Feminine Hygiene Products Market Research Report: https://www.imarcgroup.com/feminine-hygiene-products-market

Body Contouring Market Research Report: https://www.imarcgroup.com/body-contouring-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

USA: +1-631-791-1145

Email: sales@imarcgroup.com

Website: https://www.imarcgroup.com

Follow us on twitter: @imarcglobal

 

Advertisements

Global Artificial Organs Market Overview 2018, Demand by Regions, Share and Forecast to 2023

The global artificial organs market has been witnessing a healthy growth. This can be attributed to ageing population, rising number of road accidents, scarcity of organ donors, advancements in the technology, etc.

artificial-organs-market

Request sample report @ http://www.imarcgroup.com/request?type=report&id=833&flag=B

The latest report by IMARC Group, titled “Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global artificial organs market reached a value of more than US$ 12 Billion in 2016. Artificial organs are man-made electrical devices that are integrated into a human body so as to replace a damaged or missing natural organ. They are composed of plastic that is seeded with stem cells from the transplant recipient, due to which the body’s immune system does not reject the artificial organ. These bio-artificial devices can temporarily or permanently substitute organs and provide support for restoring a specific function so that the patient can heal rapidly. Artificial organs include pacemaker, artificial heart and artificial substitutes for missing limbs or performing kidney functions.

Highlights of the global artificial organs market:

  • Ageing population and growing cases of chronic diseases are major growth driving factors.
  • Artificial kidney represents the most popular product type, leading the artificial organs market.
  • North America represents the largest market, holding the majority of the global share.

A rise in geriatric population, growing prevalence of chronic diseases and a surge in the number of people suffering from organ failures and limb amputation are the major growth-inducing factors for the artificial organs market. Further, unavailability of organ donors at the time of requirement coupled with growing public awareness about the advancements in the healthcare sector are contributing to the growth of the market. As a result of rising incidences of road accidents and injuries leading to amputations, the demand for artificial organs has further increased. Furthermore, advancements in technological innovations to develop affordable artificial organs are also projected to aid the market growth. According to the report, the market is expected to reach a value of more than US$ 20 Billion by 2022, exhibiting a CAGR of nearly 7% during 2017-2022.

On the basis of key applications, artificial kidney represents the largest product type. Other major product types include artificial heart, cochlear implants and artificial pancreas. On the basis of region, North America represents the largest market for artificial organs, accounting for the majority of the total global share. Other major regions include Europe, Asia-Pacific, Latin America, and Middle East and Africa. On evaluating the competitive landscape of the market, it is found that the key players include Abiomed, Inc., Heartware International, Inc., Edwards Lifesciences Corp, Boston Scientific Corporation and Cochlear Limited.

Read full report with TOC @ http://www.imarcgroup.com/artificial-organs-market

The report by IMARC Group has examined the global artificial organs market on the basis of:

Type:

  • Artificial Kidney
  • Artificial Heart
  • Artificial Pancreas
  • Cochlear Implants
  • Others

Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Major manufacturers:

  • Abiomed, Inc.
  • Heartware International, Inc.
  • Edwards Lifesciences Corp
  • Boston Scientific Corporation
  • Cochlear Limited

Browse related reports:

Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Breast Pump Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

USA: +1-631-791-1145

Email: sales@imarcgroup.com

Website: http://www.imarcgroup.com

Follow us on twitter : @imarcglobal

Global Feminine Hygiene Products Market Overview 2017, Demand by Regions, Types and Analysis of Key Players

The global feminine hygiene products market has been witnessing a positive growth. This is due to the rising awareness of personal hygiene among women, product innovations and various awareness campaigns and programmes.

Request a sample report: http://www.imarcgroup.com/request?type=report&id=853&flag=B

The latest report by IMARC Group, titled “Feminine Hygiene Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global feminine hygiene products market reached a value of around US$ 23 Billion in 2016. Feminine hygiene products play a significant role in improving and maintaining the well-being and reproductive health of women. These products are made up of raw materials such as rayon, viscose and cellulose wood fluff pulp. Feminine hygiene products are mainly associated with menopause, menstruation, genital cleanliness, contraception and maternity. Over the past two decades, the popularity of these products has increased due to a rise in safety concerns for personal hygiene among women.

Highlights of global feminine hygiene products market:

  • A shift towards organic products remains the primary growth-inducing factor.
  • Sanitary pads represent the largest product type, accounting for majority of the share.
  • Asia Pacific dominates the market owing to the increasing demand in the region.

    The growth of the global feminine hygiene products market is primarily attributed to a shift towards organic products which are compostable, biodegradable and eco-friendly. In developing countries, there is a high demand for good quality products, whereas, premium products remain popular in developed countries. In addition, several awareness campaigns and programmes have also been organised by different NGOs and governments so as to raise awareness for maintaining an appropriate personal hygiene among women. Moreover, manufacturers are coming up with new product varieties in order to increase their consumer base. As a result, the global feminine hygiene products market is expected to be valued at nearly US$ 32 Billion, exhibiting a CAGR of more than 5% during 2017-2022.

On the basis of products, sanitary pads clearly show a dominance in the market followed by panty liners, tampons, and spray and internal cleaners. Based on distribution channel, supermarkets and hypermarkets represent the largest distribution channel in the market. It is followed by specialty stores, beauty stores and pharmacies, and online. Region-wise, Asia-Pacific currently accounts for the majority of the total global share owing to rapidly increasing demand for feminine hygiene products. Other major regions include North America, Europe, Middle East and Africa, and Latin America. The competitive landscape of the market has also been analysed with some of the key players operating in the market being Procter & Gamble, Edgewell Personal Care, Unicharm, Kimberly-Clark Corporation and Kao Group.

Read full report with TOC: http://www.imarcgroup.com/feminine-hygiene-products-market

The report by IMARC Group has examined the global feminine hygiene products market on the basis of:

Product:

  • Sanitary Pads
  • Panty Liners
  • Tampons
  • Spray and Internal Cleaners

Distribution Channel

  • Supermarkets and Hypermarkets
  • Specialty Stores
  • Beauty Stores and Pharmacies
  • Online
    Region
  • Asia Pacific
  • North America
  • Europe
  • Middle East and Africa
  • Latin America
    Key Players
  • Procter & Gamble
  • Edgewell Personal Care
  • Unicharm
  • Kimberly-Clark Corporation
  • Kao Group

Browse related reports:

DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Breast Pump Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter : @imarcglobal

Global Cataract Surgical Devices Market 2017: Region Wise Analysis of Top Players in Market By Types and Application

The global cataract surgical devices market has witnessed a steady growth over the years. This can be accredited to the availability of a wide range of modern and innovative ophthalmic devices coupled with an ageing population.

Request sample report: http://www.imarcgroup.com/request?type=report&id=840&flag=B

The latest report by IMARC Group, titled “Cataract Surgical Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global cataract surgical devices market reached a value of nearly US$ 7 Billion in 2016. Cataract is an eye disease in which things appear blurry, hazy or less colourful, resulting in cloudy or opaque vision. It can be caused due to ageing, diabetes, smoking, trauma or prolonged exposure to sunlight. Cataract can be removed using certain surgical instruments and devices, such as ophthalmic viscoelastic devices, drapes, gloves, balanced salt solution, forceps, irrigation set, and intraocular lenses. These devices are safe and help in effectively restoring vision to the eye.

Highlights of the global cataract surgical devices market:

  • Rapid increase in the prevalence of ocular disorders is the key factor driving the growth of the market.
  • Intraocular lenses are the most popular product type, holding the largest share.
  • North America represents the largest market, accounting for the majority of the global share.

A rise in the geriatric population worldwide in confluence with growing prevalence of ocular diseases and technological advancements in the healthcare sector represent the major factors influencing the cataract surgical devices market. On the other hand, a lack of awareness among the individuals regarding the benefits of cataract surgeries along with low healthcare insurance coverage impede the growth of the cataract surgical devices market in the emerging regions. However, the governments of numerous countries are introducing healthcare programmes to reduce the burden of cataract-related diseases on the patients, further creating profitable opportunities for the manufacturers. Owing to these factors, the global cataract surgical devices market is further expected to reach a value of around US$ 9 Billion by 2022, exhibiting a CAGR of nearly 4% during 2017-2022.

The market is segmented on the basis of product type into Intraocular Lenses (IOLs), femtosecond laser, Ophthalmic Viscoelastic Devices (OVDs), phacoemulsification equipment and others. Currently, IOLs represent the most popular product type, accounting for the majority of the market share. On the basis of application, the market is segregated in hospitals, eye care clinics, and eye treatment and surgical centres, wherein hospital accounts for the largest share. On a regional basis, North America currently accounts for the largest share. Other major regions include Europe, Asia Pacific, Latin America, and Middle East and Africa. On evaluating the competitive landscape of the market, it is found that the global players are Abbott Laboratories, Hoya Corporation, Carl Zeiss Meditec, Alcon Laboratories, Inc., and Essilor.

Read full report with TOC: http://www.imarcgroup.com/cataract-surgical-devices-market

The report by IMARC Group has examined the global cataract surgical devices market on the basis of:

Product Type:

  • Intraocular Lenses (IOLs)
  • Femtosecond laser
  • Ophthalmic Viscoelastic Devices (OVDs)
  • Phacoemulsification Equipment

Application:

  • Hospitals
  • Eye Care Clinics
  • Eye Treatment and Surgical Centres

Region:

  •  North America
  •  Europe
  •  Asia Pacific
  •  Latin America
  •  Middle East and Africa

Key Players:

  • Abbott Laboratories
  • Hoya Corporation
  • Carl Zeiss Meditec
  • Alcon Laboratories, Inc
  • Essilor

Browse related reports:

Eyewear Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Exercise Bike Market Overview 2017, Demand by Regions, Types and Analysis of Key Players

The global exercise bike market has witnessed a healthy growth over the past several years. This can be accredited to the rising health issues, growing trend of fitness clubs, product innovations and inflating disposable incomes.

Request sample report: http://www.imarcgroup.com/request?type=report&id=842&flag=B

The latest report by IMARC Group, titled “Exercise Bike Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global exercise bike market reached a value of US$ 476 Million in 2016. Exercise bike, also known as exercise bicycle, spinning bike, spin bike, or exercycle, is a stationary device similar to a bicycle and consisting of a saddle, pedals, and some form of handlebars. These bikes are used as an exercise equipment for the purpose of increasing general fitness and training. The recurring cycling motion results in burning fat and exercising the muscles. This low-impact, safe, and effective cardiovascular exercise provided by the exercise bikes has made them highly popular across the globe.

Highlights of the global exercise bike market:

  • Increasing health awareness among the consumers remains the key growth inducing factor.
  • Recumbent exercise bikes represent the most popular product type.
  • North America is the leading market, holding the majority of the total share.

The global exercise bike market is driven by the growing number of lifestyle diseases such as obesity, diabetes, hypertension and stress, and the subsequent health consciousness among the consumers. In line with this, rising number of fitness clubs, gyms and health centers have stimulated the demand for exercise bikes globally. Moreover, manufacturers are now working extensively on product innovations, to widen their consumer base. Some of the new technologies include bikes that allow the rider to watch live stream videos on its screen while cycling in the studio, or cycle through different landscapes around the world by virtual reality. Additionally, on account of surging disposable incomes, consumers are now willing to spend more on their fitness and also prefer to own private equipment within the comfort of their homes. Owing to the abovementioned factors, the market is expected to reach a value of US$ 575 Million by 2022, exhibiting a CAGR of more than 3% during 2017-2022.

The market has been segmented on the basis of product type, including recumbent exercise bikes, upright exercise bikes and others such as indoor bikes, dual action stationary bikes, etc. Amongst these, recumbent exercise bikes represent the most popular product type. Based on applications, the home consumers segment accounts for the largest share, followed by gyms/health clubs. Region-wise, North America represents the leading market, followed by Europe and Asia Pacific. Other regions include Latin America, and Middle East and Africa. On evaluating the competitive landscape of the market, it is found that Brunswick Corporation, Icon Health & Fitness, Inc., Nautilus, Precor and Technogym are the key players operative in the market.

Read full report with TOC: http://www.imarcgroup.com/exercise-bike-market

The report by IMARC Group has examined the global exercise bike market on the basis of:

Product Type:

  • Recumbent Exercise Bikes
  • Upright Exercise Bikes
  • Others (Dual Action Stationary Bikes, Indoor Bikes, etc.)

Applications:

  • Home Consumers
  • Gyms/Health Clubs

Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Key Players:

  • Brunswick Corporation
  • Icon Health & Fitness, Inc.
  • Nautilus
  • Precor
  • Technogym

Browse related reports:

Body Contouring Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Cataract Surgical Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

 

Global Generic Drugs Market Size, Share, Growth And Forecast 2017-2022

The global generic drugs market has witnessed a rapid growth in recent years. Some of the factors which have helped in the market growth of generic drugs are their performance characteristics, cost-effectiveness, reduced investments in R&D, patent expiry of the branded drugs, etc.

The latest report by IMARC Group titled, “Generic Drugs Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global generic drugs market reached a value of nearly US$ 230 Billion in 2016, growing at a CAGR of more than 7% during 2010-2016. Generic drugs have the same active ingredients and possess similar performance characteristics as their branded variants, such as strength, quality, form, effect, intended use, side effects, route of administration, therapeutic effect, etc. These drugs are manufactured under the same rules and regulations of manufacturing practices required for branded drugs. However, they are sold under their chemical names rather than the brand names.

Request sample of the report: http://www.imarcgroup.com/request?type=report&id=549&flag=B

Generic Drugs Market

Highlights of the global generic drugs market:

  • The market is driven primarily by their affordability.
  • The USA represents the largest market for these drugs, accounting for the majority of the share.
  • The market is expected to reach a value of around US$ 360 Billion by 2022.

To get more information, please visit @ http://www.imarcgroup.com/generic-drug-manufacturing-plant

The cost-effectiveness of the generic drugs has emerged as one of the major factors which has contributed in influencing the growth of the market. These drugs require low investments in research & development, which brings down the cost of manufacturing significantly. This has encouraged the government and third-party payers to promote the manufacturing of these drugs and save billions of dollars on healthcare expenditures. Apart from this, the patent expiry of the branded drugs is also an essential factor which provides encouragement to the generic drugs market. Most branded drugs come with a lifespan of 20 years during which other manufacturers cannot sell the branded drugs under their companies’ name. However, when the patent protection expires, the manufacturing rights of these drugs is available to the other manufacturers. Some of the other growth inducing factors include rising aging-population, increasing prevalence of chronic diseases, and incentives offered to physicians and pharmacists to promote generics. Further, the market is expected to reach a value of nearly US$ 360 Billion by 2022.

The report has segmented the market on a regional basis. Some of the major markets for generic drugs include USA, China, Brazil, Germany and France. Amongst these, USA is the largest market, accounting for the majority of the share. An analysis of the competitive landscape provides the details of the key players operative in the market. Some of the major players are Teva Pharmaceuticals, Novartis–Sandoz, Mylan, Freseunis, and Hospira.

The report has examined the global generic drugs market on the basis of:

Key Regions:

  • USA
  • China
  • Brazil
  • Germany
  • France

    Key Players:

  • Teva Pharmaceuticals
  • Novartis – Sandoz
  • Mylan
  • Freseunis
  • Hospira

Browse more related reports:

US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
Tel No: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

US Diabetes Market Share, Size, Price Trends and Forecast 2017-2022

The US diabetes market has witnessed a rapid growth in recent years. A significant growth in the number of diabetic patients is the major factor which has contributed in influencing the demand for diabetes management products.

The latest report by IMARC Group titled, “US Diabetes Market Report: 2017 – 2022”, finds that the US diabetes market reached a value of nearly US$ 33 Billion in 2016, growing at a CAGR of more than 13% during 2009-2016. The socio-economic structure of the United States has changed dramatically over the past several years. Some of the drastic modifications the Americans have undergone include the sudden rise in the per capita income, the thriving food processing industry, and changing lifestyle patterns. These transformations have come to evolve as the root cause of the prevalence of some of the deadly diseases in the region. Diabetes is one of them, which has taken more than 27 Million patients under its sway, representing the world’s third largest patient pool in 2016. Some of the major causes of diabetes among the Americans are obesity, consumption of processed foods, stress, increasing aged-population, sedentary lifestyle, and genetic factors.

Request sample of the report: http://www.imarcgroup.com/request?type=report&id=688&flag=B

US Diabetes

Highlights of the US diabetes market:

  • A huge number of diabetic patients is the biggest driving factor for the growth of the market.
  • Insulin represents the largest drug type, accounting for the majority of the share.
  • The market is expected to reach a value of around US$ 67 Billion by 2022.

To get more information, please visit @ http://www.imarcgroup.com/us-diabetes-market

The disposable incomes have, however, also helped in availing the consumers access to expensive treatments of diseases. As a result of being a region where the consumers earn and spend exceedingly, the manufacturers in the pharmaceuticals industry have secured plenty of opportunities to create and develop a market for their products. With a large number of diabetic patients, the demand for diabetes management products has increased significantly, such as insulin injection devices and insulin pumps, insulin therapies, oral and injectable diabetes drugs, blood glucose monitoring devices, etc. Owing to this growing demand, the market is further expected to reach a value of around US$ 67 Billion by 2022.

The market is segmented on the basis of drug type which includes insulin and oral anti-diabetics. Currently, insulin represents the largest market, accounting for the majority of the share. An analysis of the competitive landscape provides the details of the key players operative in the market. Some of the major players in the US diabetes market are Merck, Astra Zeneca, Novo Nordisk, and Johnson and Johnson.

The report has segmented the US diabetes market on the basis of:

Drug Type:

  • US Oral Antidiabetics Market
  • US Insulin Market

    Key Players:

  • Merck
  • Astra Zeneca
  • Novo Nordisk
  • Johnson and Johnson

Browse more related reports:

Japan Diabetes Market Expected to Reach Nearly US$ 5 Million by 2022

Russia Diabetes Market Report: 2017 – 2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise

Contact Us

IMARC Group
Tel No: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal